ConductScience.org, home

Paper626490

Chemotherapeutic evaluation of 5-episisomicin (Sch 22591), a new semisynthetic aminoglycoside.

Waitz JA and 3 others. Antimicrob Agents Chemother, 1978. Cited by 25 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Chemotherapeutic evaluation of 5-episisomicin (Sch 22591), a new semisynthetic aminoglycoside. Papers, record 626490. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/626490

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chemotherapeutic evaluation of 5-episisomicin (Sch 22591), a new semisynthetic aminoglycoside.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
1.13
iCite
Revised in PubMed
2021-05-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Waitz JAJ A
2Miller GHG H
3Moss E JrE
4Chiu PJP J

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GentamicinsMajor topic
SisomicinMajor topic
Animals
Cats
Dogs
In Vitro Techniques
Isomerism
Male
Mice
Microbial Sensitivity Tests
Rats

Source PubMed

References6

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1879,737Renal pharmacology of netilmicin.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/879737PubMed
21,008,541Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/1008541PubMed
34,468,277Mutamicins; biosynthetically created new sisomicin analogues.J Antibiot (Tokyo)1974https://conductscience.org/library/papers/4468277PubMed
44,692,995Kinetics of cephaloridine in experimental wounds.Am J Med Sci1973https://conductscience.org/library/papers/4692995PubMed
54,694,402Concentration of antibacterial agents in interstitial tissue fluid.Br Med J1973https://conductscience.org/library/papers/4694402PubMed
64,992,170Antibiotic 6640. 3. Biological studies with antibiotic 6640, a new broad-spectrum aminoglycoside antibiotic.J Antibiot (Tokyo)1970https://conductscience.org/library/papers/4992170PubMed

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
20,805,391Synthesis and spectrum of the neoglycoside ACHN-490.Antimicrob Agents Chemother2010https://conductscience.org/library/papers/20805391PubMed
6,967,2965-epi-Sisomicin and 5-epi-Gentamicin B: substrates for aminoglycoside-modifying enzymes that retain activity against aminoglycoside-resistant bacteria.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6967296PubMed
6,376,062Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.Drugs1984https://conductscience.org/library/papers/6376062PubMed
3,914,858Comparison of aminoglycoside resistance patterns in Japan, Formosa, and Korea, Chile, and the United States.Antimicrob Agents Chemother1985https://conductscience.org/library/papers/3914858PubMed
3,518,623Aminoglycoside research 1975-1985: prospects for development of improved agents.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3518623PubMed
742,870Comparison of 5-episisomicin (Sch 22591), gentamicin, sisomicin, and tobramycin in treatment of experimental Pseudomonas infections in mice.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/742870PubMed
697,347Activity of 5-episisomicin compared with that of other aminoglycosides.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/697347PubMed
697,346In vitro studies with Sch 21420 and Sch 22591: activity in comparison with six other aminoglycosides and synergy with penicillin against enterococci.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/697346PubMed
101,131In vitro activity of 5-episisomicin in bacteria resistant to other aminoglycoside antibiotics.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/101131PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/626490

GET https://conductscience.org/api/papers/v1/626490/authors